Literature DB >> 9221299

[Genesis, pathophysiology and clinical aspects of cardiac arrhythmias. Characterization of the risk patient].

G Steinbeck1.   

Abstract

Extrasystoles and both supraventricular and ventricular tachycardias may occur as a complication of almost any underlying cardiac disease and many extracardiac causes; on the other hand, also a patient without any detectable structural heart disease may present with these arrhythmias. Refined mapping techniques of the intracardiac conduction process have let to important new informations about the pathophysiology of sustained tachycardias (focal impulse formation, macro-reentry) with practical consequences, for example when ablation of these arrhythmias by radiofrequency catheter ablation is considered. Cardiac arrhythmias may lead to both typical and atypical symptoms. Finally, the patient at risk of sudden cardiac death is characterized. One needs to differentiate patients who have survived a life-threatening event of ventricular tachycardia or have been successfully resuscitated from cardiac arrest (both situations usually need life-long antiarrhythmic interventions for secondary prophylaxis) from patients who also are at high risk, however, are asymptomatic until now. For the latter population, symptoms due to extrasystoles or assessment of the severity of ventricular ectopic beats by the Lown classification are of minor importance; most emphasis in this regard, however, must be placed on the type and severity of underlying cardiac disease.

Entities:  

Mesh:

Year:  1997        PMID: 9221299     DOI: 10.1007/bf03043256

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  7 in total

1.  Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy.

Authors:  H L Kennedy; J A Whitlock; M K Sprague; L J Kennedy; T A Buckingham; R J Goldberg
Journal:  N Engl J Med       Date:  1985-01-24       Impact factor: 91.245

2.  Approaches to sudden death from coronary heart disease.

Authors:  B Lown; M Wolf
Journal:  Circulation       Date:  1971-07       Impact factor: 29.690

3.  Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy.

Authors:  T Meinertz; T Hofmann; W Kasper; N Treese; H Bechtold; U Stienen; T Pop; E R Leitner; D Andresen; J Meyer
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

4.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

5.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

6.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

Review 7.  Atrial fibrillation and stroke. Three new studies, three remaining questions.

Authors:  G W Albers
Journal:  Arch Intern Med       Date:  1994-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.